Genetic Brain Disorder Explained

Researchers uncover a mutation responsible for a rare neurological condition.

Written byRina Shaikh-Lesko
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, CHRISTOPH BOCKA rare neurological disorder is caused by a single mutation in the CLP1 gene, according to two papers published this week (April 24) in Cell. One team, led by James Lupski at the Baylor College of Medicine in Houston, Texas, studied the disorder in children as well as in a mouse model. The other team, co-led by Murat Gunel of Yale University, Frank Bass of the Academic Medical Center in Amsterdam, the Netherlands, and Joseph Gleeson of the University of California, San Diego (UCSD), focused on tracing the genetic defect to its origins.

Babies with this disorder are born with small, deformed brains, are likely to have siezures, never learn to talk, and have progressive muscle weakness. The Baylor team used exome sequencing to identify a single mutation in the CLP1 gene that affected five families in Turkey. Study coauthor Josef Penninger of the Austrian Academy of Sciences in Vienna demonstrated that, in mice, the gene affected the survival of critical brain stem cells.

“We had patients with an interesting phenotype (symptoms) and a novel gene but no evidence from the lab that these mutations are disease-causing. They had a model organism, a mouse, but they didn't have evidence that it affected people. It was a perfect storm,” study coauthor, geneticist Wojciech Wiszniewski of Baylor, told Reuters.

The ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies